Analysts' average 12-month price target for AMGEN is $370.
Get informed when a big investor buys or sells
+ Follow$419.38
21 analysts in the last 4 months
High: $450 | Low: $230
No recommendations in the last 4 months.
AMGEN (AMGN) currently reports a target price of $370. Use the charts on this page to explore AMGEN's target price history and peer comparisons.
Analysts' average 12-month price target for AMGEN is $370, about 11.1% downside from the current share price of $419.38. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $370, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AMGEN, and consider following AMGN for alerts when major investors trade the stock.
AMGEN is classified in the Healthcare sector. On target price, it currently shows $370. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMGN with unrelated industries.